Table 2 Baseline cardiovascular characteristics for all patients
|  | RA (n = 64) | PsA (n = 29) | AS (n = 20) | MTX (n = 49) | anti-TNF ± MTX (n = 6) |
|---|---|---|---|---|---|
Cardiovascular risk factors | |||||
 Hypertension | 17 (27) | 7 (24) | 6 (30) | 9 (18) | 21 (33) |
 BMI (kg/m2), median (range) | 26 (19–41) | 26 (19–39) | 28 (22–36) | 26 (20–39) | 27 (20 – 41) |
 Hyperlipidemia | 11 (17) | 3 (10) | 3 (15) | 9 (18) | 8 (12) |
 Current smokers | 20 (31) | 6 (21) | 10 (50) | 15 (31) | 21 (33) |
 Family history of CVD or death | 33 (52) | 13 (45) | 10 (50) | 24(50) | 32 (50) |
 Diabetes | 3 (5) | 0 (0) | 1 (5) | 0 (0) | 4 (6) |
Medical history | |||||
 Previous myocardial infarction | 5 (8) | 0 (0) | 2 (10) | 2 (4) | 5 (8) |
 Angina pectoris | 2 (3) | 1 (3) | 2 (10) | 2 (4) | 3 (5) |
Endothelial dysfunction | |||||
 RHI, median (range) | 1.89 (1.24–2.94) | 2.06 (1.45–2.94) | 1.81 (1.37–2.72) € | 1.93 (1.24–2.76) | 1.82 (1.37–2.94) |
 ED | 22 (34) | 9 (31) | 9 (45) | 18 (37) | 22 (34) |
 RHI, median (range) for patients with ED | 1.47 (1.24–1.65) | 1.56 (1.45–1.64) | 1.52 (1.37–1.64) | 1.49 (1.24–1.63) | 1.52 (1.37–1.65) |